139 related articles for article (PubMed ID: 14735471)
1. Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing.
Herrero Y Calle M; Cornelis JJ; Herold-Mende C; Rommelaere J; Schlehofer JR; Geletneky K
Int J Cancer; 2004 Mar; 109(1):76-84. PubMed ID: 14735471
[TBL] [Abstract][Full Text] [Related]
2. Regression of glioma in rat models by intranasal application of parvovirus h-1.
Kiprianova I; Thomas N; Ayache A; Fischer M; Leuchs B; Klein M; Rommelaere J; Schlehofer JR
Clin Cancer Res; 2011 Aug; 17(16):5333-42. PubMed ID: 21715567
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.
Lacroix J; Leuchs B; Li J; Hristov G; Deubzer HE; Kulozik AE; Rommelaere J; Schlehofer JR; Witt O
Int J Cancer; 2010 Sep; 127(5):1230-9. PubMed ID: 20087864
[TBL] [Abstract][Full Text] [Related]
4. Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.
Geletneky K; Hartkopf AD; Krempien R; Rommelaere J; Schlehofer JR
J Biomed Biotechnol; 2010; 2010():350748. PubMed ID: 20224643
[TBL] [Abstract][Full Text] [Related]
5. Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.
Rubio MP; Guerra S; Almendral JM
J Virol; 2001 Dec; 75(23):11573-82. PubMed ID: 11689639
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells.
Geletneky K; Hartkopf AD; Krempien R; Rommelaere J; Schlehofer JR
Bioeng Bugs; 2010; 1(6):429-33. PubMed ID: 21468212
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.
Di Piazza M; Mader C; Geletneky K; Herrero Y Calle M; Weber E; Schlehofer J; Deleu L; Rommelaere J
J Virol; 2007 Apr; 81(8):4186-98. PubMed ID: 17287256
[TBL] [Abstract][Full Text] [Related]
8. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
[TBL] [Abstract][Full Text] [Related]
9. Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?
Leske H; Haase R; Restle F; Schichor C; Albrecht V; Vizoso Pinto MG; Tonn JC; Baiker A; Thon N
Anticancer Res; 2012 Apr; 32(4):1137-44. PubMed ID: 22493342
[TBL] [Abstract][Full Text] [Related]
10. Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro.
Li X; Rhode SL
Virology; 1991 Sep; 184(1):117-30. PubMed ID: 1831309
[TBL] [Abstract][Full Text] [Related]
11. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells.
Dupressoir T; Vanacker JM; Cornelis JJ; Duponchel N; Rommelaere J
Cancer Res; 1989 Jun; 49(12):3203-8. PubMed ID: 2541900
[TBL] [Abstract][Full Text] [Related]
13. The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.
Alkassar M; Gärtner B; Roemer K; Graesser F; Rommelaere J; Kaestner L; Haeckel I; Graf N
J Neurooncol; 2011 Sep; 104(3):715-27. PubMed ID: 21607667
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1.
Chen YQ; de Foresta F; Hertoghs J; Avalosse BL; Cornelis JJ; Rommelaere J
Cancer Res; 1986 Jul; 46(7):3574-9. PubMed ID: 3011251
[TBL] [Abstract][Full Text] [Related]
15. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
Giese NA; Raykov Z; DeMartino L; Vecchi A; Sozzani S; Dinsart C; Cornelis JJ; Rommelaere J
Cancer Gene Ther; 2002 May; 9(5):432-42. PubMed ID: 11961666
[TBL] [Abstract][Full Text] [Related]
16. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
18. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
Moehler M; Blechacz B; Weiskopf N; Zeidler M; Stremmel W; Rommelaere J; Galle PR; Cornelis JJ
Cancer Gene Ther; 2001 Mar; 8(3):158-67. PubMed ID: 11332986
[TBL] [Abstract][Full Text] [Related]
19. LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.
Paglino JC; Ozduman K; van den Pol AN
J Virol; 2012 Jul; 86(13):7280-91. PubMed ID: 22553327
[TBL] [Abstract][Full Text] [Related]
20. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
